Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
3 studies found for:    17051156 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting SL-401 in Combination With Pomalidomide and Dexamethasone in Relapsed or Relapsed and Refractory Multiple Myeloma
Condition: Multiple Myeloma
Intervention: Drug: SL-401/ Pomalidomide/ Dexamethasone
2 Active, not recruiting Study of Continuous Dosing of Sunitinib in Non GIST Sarcomas With Concomitant Radiotherapy
Condition: Non GIST Sarcomas
Intervention: Drug: sunitinib
3 Active, not recruiting Primary Operation in SYnchronous meTastasized InVasivE Breast Cancer
Conditions: Synchronous Metastasized Breast Cancer;   Circulating Tumor Cells
Interventions: Procedure: Surgery;   Procedure: Surgery on Demand

Indicates status has not been verified in more than two years